Unusual Metastatic Sites of Testis and Rectum in Prostate Cancer Detected by 68 Ga-PSMA-11 PET/CT Imaging at Initial Staging.
Rahul V ParghaneSandip BasuPublished in: World journal of nuclear medicine (2024)
Imaging plays a pivotal role in defining the extent of disease and deciding therapeutic strategies in recently diagnosed high-risk prostate cancer. Standard-of-care conventional imaging may often miss rare metastatic disease sites. We herein present a unique case of prostate cancer where 68 Ga-PSMA-11 positron emission tomography (PET)/computed tomography (CT) detected two unusual metastatic sites (testis and rectum) in a single patient at initial staging, resulting in an accurate determination of the extent of disease, more tailored multimodal treatment planning, and exploration of the theragnostic potential.
Keyphrases
- affordable care act
- pet ct
- positron emission tomography
- prostate cancer
- computed tomography
- high resolution
- radical prostatectomy
- squamous cell carcinoma
- healthcare
- small cell lung cancer
- pet imaging
- magnetic resonance imaging
- image quality
- lymph node
- climate change
- contrast enhanced
- risk assessment
- palliative care
- quality improvement